Back grey_arrow_rt.gif
 
Archived NATAP Articles from December 2003
 
null.gif
 
 
  1. Renal Manifestations of HIV - (12/31/03)
     
  2. Norvir Price Increase - (12/31/03)
     
  3. Early vs Late Initiation of Antiretroviral Therapy for HIV Infection: A Scientific Roundtable Meeting - (12/30/03)
     
  4. Stampede of Diabetes as U.S. Races to Obesity - (12/29/03)
     
  5. Glomerular filtration rate predicts seroconversion after hepatitis B vaccination - (12/29/03)
     
  6. Abbott says it's awaiting U.S. approval for mad cow test - (12/29/03)
     
  7. Drugs in development hold promise for patients with HIV and HBV coinfection - (12/29/03)
     
  8. Epoetin alfa allows continuation of antiviral therapy in anemic HCV-infected patients - (12/29/03)
     
  9. Norvir Price Increase: Abbott letter to doctors and clinicians - (12/29/03)
     
  10. Overweight & Fatty Liver Accelerates Activity and Progression of HCV - (12/29/03)
     
  11. HCV-Coinfection Is Associated with Diabetes and CD4 Decline - (12/29/03)
     
  12. Didanosine Intensification in NRTI-Experienced Patients - (12/22/03)
     
  13. Liver Adverse Events are Most Common in HIV - (12/22/03)
     
  14. Increasing Syphilis Infections Among MSM By Meeting Sex Partners on the Internet - (12/22/03)
     
  15. CD4 Counts May Bounce Back, but Does Immunity? - (12/22/03)
     
  16. Antiretrovirals and Cardiovascular Disease: Is HAART Bad for Your Heart? - (12/22/03)
     
  17. PDF FORMAT - Clinical Applications of Imaging Technologies in the Management of the HIV Lipodystrophy Syndromes - (12/18/03)
     
  18. EACS - CC chemokine receptor 5 Delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia - (12/16/03)
     
  19. EACS - Pegasys plus Ribavirin for HCV Treatment in HIV/HCV Coinfection in spain: PRESCO Study - (12/16/03)
     
  20. EACS - THE TREATMENT OF ACUTE HEPATITIS C INFECTION IN HIV-COINFECTED PATIENTS - A RETROSPECTIVE ANALYSIS OF 8 CASES IN A MULTICENTER SETTING - (12/16/03)
     
  21. EACS - The Impact of Depression on HAART Effectiveness - (12/16/03)
     
  22. EACS - ALT & AST Changes Over 48 weeks in HIV+ Therapy-Naïve Adults with Hepatitis B and/ot C Co-Infection Treated with Fosamprenavir QD or Nelfinavir: SOLO Study - (12/16/03)
     
  23. EACS - LIVER TOXICITY OF LOPINAVIR/RITONAVIR-CONTAINING REGIMENS IN HIV-INFECTED PATIENTS WITH OR WITHOUT HEPATITIS C VIRUS (HCV) CO-INFECTION - (12/16/03)
     
  24. New CDC HIV Prevention Funding Emphasizes Effectiveness, Focuses on Those Already Infected - (12/16/03)
     
  25. Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world - (12/16/03)
     
  26. Changes in HIV Prevention Spending Priorities - (12/16/03)
     
  27. HIV drug resistance brings calls for new medicines - (12/16/03)
     
  28. Changes in CD4 Cells During HIV Treatment Interruption - (12/16/03)
     
  29. Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection: AZT/3TC vs d4T/ddI and nelfinavir vs efavirenz - (12/13/03)
     
  30. One HAART regimen may be best for first-line HIV therapy - (12/13/03)
     
  31. Adverse Events Are A Leading Cause For HIV Treatment Discontinuation - (12/13/03)
     
  32. Therapy for HDV! - (12/13/03)
     
  33. Alanine Aminotransferase Levels Predict Insulin Resistance in HIV Lipodystrophy - (12/08/03)
     
  34. Increased Risk for Fat Loss in HIV+ Women Observed in WIHS Study - (12/08/03)
     
  35. Sexual Activity as a Risk Factor for Hepatitis C - (12/05/03)
     
  36. Future Therapy of Hepatitis C - (12/05/03)
     
  37. BRISTOL-MYERS SQUIBB FUNDING NEW PEDIATRIC HIV/AIDS CENTER IN AFRICA - (12/04/03)
     
  38. Hepatitis C's time bomb - (12/01/03)